Neopterin [neopterin]
- Terms
-
2-amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinon
-
2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone
Monapterin
Neopterin, (erythro-D)-Isomer
Neopterin, (erythro-L)-Isomer
Neopterin, (R*, R*)-Isomer
Neopterin, (threo-D)-Isomer
Neopterin, (threo-L)-Isomer
Umanopterin
A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of BIOPTERINS.
- DUI
- D019798 MeSH Browser
- CUI
- M0029376
- Previous indexing
- Biopterin/analogs & derivatives (1977-1997)
- History note
- 98; use NEOPTERIN (NM) 1979-97
- Public note
- 98; NEOPTERIN was indexed under BIOPTERIN/analogs & derivatives 1977-97
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 9
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 2
- BL
- blood 29
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 2
- CL
- classification 1
- DF
- deficiency 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 6
- IP
- isolation & purification 2
- ME
- metabolism 4
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 1
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 1
- TO
- toxicity 0
- UR
- urine 35